/PRNewswire/ Research and Markets has announced the addition of the "Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins)" report to their offering. Biopharmaceuticals is currently one of the fastest ... Pharmacy Choice, 1 month ago
Biotherapeutics Market Report: Novel Formulation and Delivery Approaches - Focus on Antibodies and Proteins - Financial Buzz, 1 month ago
BiondVax Pharma (NASDAQ:BVXV) Zacks Investment Research raised their FY2016 earnings per share (EPS) estimates for shares of BiondVax Pharma in a research report issued to clients and investors on Monday, Zacks Investment Research reports. Zacks ...American Banking News - Earnings, 3 weeks ago BiondVax Pharma (BVXV) Forecasted to Earn Q1 2016 Earnings of ($0.01) Per Share Ticker Report, 3 weeks ago
Scientists at the Weizmann Institute may have found the cure for prostate cancer, at least if it is caught in its early stages via a drug that doctors inject into cancerous cells and treat with infrared laser illumination. Using a therapy ...The Times Of Israel, 1 month ago Revolutionary therapy for prostate cancer coming to Europe Israel 21c, 1 month ago
CELL SOURCE, INC. - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
This Management Discussion and Analysis ("MD&A") contains "forward-looking statements," which represent our projections, estimates, expectations or beliefs concerning among other things, financial items that relate to management's future plans or ...Pharmacy Choice, 1 month ago
on your WebpageAdd Widget >Get your members hooked!